China accuses drugmaker GlaxoSmithKline of bribery, fraud




International Top Stories from Associated Press (AP) show

Summary: China has accused British-based big pharm GlaxoSmithKline of offering bribes and kickbacks in order to boost sales across the country. The Ministry of Public Security said specifically that those who work for the company had bribed medical professionals and then funneled payoff money through travel agencies and other groups, The New York Times reported.